SciBase (public company)

See something wrong or missing? Let us know
Offices:
Stockholm
Business model:
B2B
Key People:
Simon Grant
Investors:
we tracked 1 investor
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

ounded in 1998, SciBase AB is a Swedish medical technology company, headquartered in Stockholm, that has developed a unique point of care device for the accurate detection of malignant melanoma.

The Scibase method is based on a technology called Electrical Impedance Spectroscopy (EIS), which uses the varying electrical properties of human tissue to categorize cellular structures and thereby detect malignancies.

Nevisense is a point-of-care device that has emerged from more than 20 years of academic research at Karolinska Institutet Stockholm and significantly increases the physician’s ability to detect and monitor skin tissue alterations.

Nevisense has strong protections through a comprehensive patent portfolio and several other combined approaches that relate to technical and clinical development.

Three consecutive and comprehensive clinical studies have been performed to date for Nevisense, with excellent clinical results. A successful pivotal study was finalized in 2012 including 1,951 patients and 2,416 lesions at 22 sites in Europe and US.

Companies with similar profile to SciBase:

CompanyCriteria
Sweden Avidicare
56%
  • Similar verticals: Hardware, Health services
  • Similar business models: B2B
  • At least one vc investor: SEB Venture Capital
  • Total raised in a similar range: 1M - 5M USD
Sweden Airsonett
46%
  • Similar verticals: Hardware, Health services
  • Similar business models: B2B
  • At least one vc investor: SEB Venture Capital
Sweden Aim Sweden
44%
  • Similar verticals: Hardware, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Finland LymphaTouch
44%
  • Similar verticals: Hardware, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Sweden Bioservo Technologies
44%
  • Similar verticals: Hardware, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Norway Listen AS
44%
  • Similar verticals: Hardware, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Norway Ably Medical
44%
  • Similar verticals: Hardware, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Finland Valkee
34%
  • Similar verticals: Hardware, Health services
  • Similar business models: B2B
Sweden ScandiNova
34%
  • Similar business models: B2B
  • At least one vc investor: SEB Venture Capital
  • Total raised in a similar range: 1M - 5M USD
Finland Naava
34%
  • Similar verticals: Hardware, Health services
  • Similar business models: B2B
Norway Conceptomed
34%
  • Similar verticals: Hardware, Health services
  • Similar business models: B2B
Denmark MagCath
34%
  • Similar verticals: Hardware, Health services
  • Similar business models: B2B
Sweden Deversify
34%
  • Similar verticals: Hardware, Health services
  • Similar business models: B2B
Sweden Irras
34%
  • Similar verticals: Hardware, Health services
  • Similar business models: B2B
Finland Valpas
34%
  • Similar verticals: Hardware, Health services
  • Similar business models: B2B
Sweden Vironova
34%
  • Similar verticals: Hardware, Health services
  • Similar business models: B2B
Denmark Coinify
34%
  • Similar business models: B2B
  • At least one vc investor: SEB Venture Capital
  • Total raised in a similar range: 1M - 5M USD
Finland Noccela
33%
  • Similar verticals: Hardware
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Norway Cytovation
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Norway Spinchip Diagnostics
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD